Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNatwest Mk.33 Regulatory News (83NF)

Share Price Information for Natwest Mk.33 (83NF)

Share Price is delayed by 15 minutes
Get Live Data
0.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: -
83NF Live PriceLast checked at - London Stock Exchange

Intraday Natwest Mk.33 Share Chart

Registration Document and Base Prospectus

31 Mar 2021 16:10

RNS Number : 1824U
Natwest Markets PLC
31 March 2021
 

Publication of NatWest Markets Plc Registration Document and Base Prospectus

The following Registration Document and Base Prospectus have each been approved by the Financial Conduct Authority and are available for viewing:

NatWest Markets Plc Registration Document

To view the full document, please paste the following URL into the address bar of your browser:

http://www.rns-pdf.londonstockexchange.com/rns/1824U_2-2021-3-31.pdf

Base Prospectus relating to the NatWest Markets Plc US$10,000,000,000 US Medium-Term Note Programme dated 31 March 2021.

To view the full document, please paste the following URL into the address bar of your browser:

http://www.rns-pdf.londonstockexchange.com/rns/1824U_1-2021-3-31.pdf

Copies of the above Registration Document and Base Prospectus have been submitted to the National Storage Mechanism and will shortly be available for inspection at:

https://data.fca.org.uk/#/nsm/nationalstoragemechanism

 

For further information, please contact:

Mark Anwender

Head of Documentation and Funding,

NatWest Treasury Markets

Tel: +44 20 7085 5143

 

 

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Base Prospectus and the Registration Document may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Base Prospectus is not addressed. Prior to relying on the information contained in the Base Prospectus you must ascertain from the Base Prospectus whether or not you are part of the intended addressees of the information contained therein.

Your right to access this service is conditional upon complying with the above requirement.

 

Legal Entity Identifier: RR3QWICWWIPCS8A4S074

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PDIUARVRAVUOOAR
Date   Source Headline
14th Jun 202312:38 pmRNSPublication of Final Terms
2nd Jun 20235:10 pmRNSPublication of Pricing Supplement
15th May 20235:59 pmRNSPublication of Final Terms
15th May 20234:55 pmRNSPublication of Final Terms
28th Apr 20234:25 pmRNSPublication of Supplementary Prospectus
28th Apr 20237:01 amRNSNWM Plc Q1 2023 Interim Management Statement
12th Apr 20234:02 pmRNSNatWest Group plc notes rating actions by S&P
27th Mar 20236:20 pmRNSPublication of Supplementary Prospectus
22nd Mar 20235:38 pmRNSPublication of Final Terms
16th Mar 202311:52 amRNSNotice of Successor Rate and Adjustment Spread
15th Mar 20233:43 pmRNSNWM Plc Registration Document and Base Prospectus
24th Feb 202312:48 pmRNSNotice of Successor Rate and Adjustment Spread
17th Feb 20233:45 pmRNSPublication of Supplementary Prospectus
17th Feb 20237:00 amRNSAnnual Financial Report - NatWest Markets Plc
17th Feb 20237:00 amRNSFinal Results - NatWest Markets Plc
12th Jan 202310:33 amRNSPublication of Final Terms
7th Dec 20225:42 pmRNSPublication of a Prospectus
2nd Dec 20225:34 pmRNSPublication of Pricing Supplement
22nd Nov 20223:26 pmRNSPublication of Final Terms
22nd Nov 20222:26 pmRNSPublication of Final Terms
4th Nov 20221:32 pmRNSPublication of Final Terms
28th Oct 20226:06 pmRNSPublication of Supplementary Prospectus
28th Oct 20227:01 amRNSNWM Plc Q3 Interim Management Statement 2022
27th Sep 20225:58 pmRNSPublication of Final Terms
26th Sep 20226:08 pmRNSNWM EMTN Prospectus Supplement
23rd Sep 202212:30 pmRNSNatWest Group notes rating actions by Moody's
15th Aug 20225:56 pmRNSPublication of Final Terms
29th Jul 20225:57 pmRNSPublication of Amended and Restated Final Terms
29th Jul 20225:45 pmRNSPublication of Supplementary Prospectus
29th Jul 20227:00 amRNSDirectorate Change
29th Jul 20227:00 amRNSInterim Results - NatWest Markets N.V.
29th Jul 20227:00 amRNSInterim Results - NatWest Markets
8th Jul 20224:45 pmRNSPublication of Final Terms
8th Jul 202212:07 pmRNSPublication of Final Terms
8th Jun 20223:33 pmRNSPublication of Final Terms
25th May 20226:19 pmRNSPublication of Final Terms
29th Apr 20224:14 pmRNSPublication of Suppl Reg Doc & Suppl.Prospcts
29th Apr 20227:00 amRNSNWM plc Q1 2022 Interim Management Statement
1st Apr 20225:02 pmRNSNatWest Markets Plc Pricing Supplement
24th Mar 202210:37 amRNSPublication of Final Terms
23rd Mar 20221:45 pmRNSPublication of Final Terms
18th Mar 202211:53 amRNSPublication of Final Terms
18th Mar 202210:22 amRNSPublication of Final Terms
18th Mar 20229:30 amRNSNatWest Markets Plc announces interim CFO
17th Mar 20223:27 pmRNSProspectus Supplement
16th Mar 20225:33 pmRNSNWM Plc Registration Document and Base Prospectus
16th Mar 20224:15 pmRNSPublication of Final Terms
28th Feb 20225:24 pmRNSPublication of Final Terms
28th Feb 20225:04 pmRNSPublication of Final Terms
18th Feb 20222:44 pmRNSPublication of Supplementary Prospectus

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.